The MEDICAL JAPAN TOKYO exhibition was successfully held in Tokyo, Japan, from October 1 to 3, 2025. As an important participant in global medical device innovation, ChoiceMMed attracted considerable attention with its display of multiple products,spotlighting its strategic innovations in the home health monitoring sector.
Aging Society, Home Care Focus.
Japan, home to one of the world's most aged populations with 29.3% of its people aged 65 or above, is experiencing a steady increase in cases of chronic respiratory diseases. This trend is underscoring the growing critical role of home oxygen therapy in chronic disease management. Capitalizing on this market need,ChoiceMMed's portable oxygen concentrator stole the spotlight at the show, attracting a stream of agents who gathered to experience the product firsthand.
Beyond oxygen concentrators, ChoiceMMed showcased a range of established products with international certifications at the exhibition. These included Fingertip Pulse Oximeter, Wrist Pulse Oximeter and cardiovascular products such as Card ECG Monitor with atrial fibrillation analysis capabilities. The offerings span multiple scenarios, from daily health monitoring to at-home chronic condition management.
During the exhibition, ChoiceMMed's booth was a hive of activity, drawing large crowds.Professional buyers, representatives from medical institutions, and distributors all showed keen interest in the innovative medical products, actively inquiring about technical details and potential cooperation opportunities.
The exhibition served as a dual validation of ChoiceMMed's technological capabilities and service excellence. During the event, ChoiceMMed established preliminary collaboration intentions with multiple distributors in the Japanese market. An industry insider from Tokyo commented, " What impressed us about ChoiceMMed is their complete product range and solid R&D capabilities—qualities that are an excellent fit for the Japanese market's emphasis on both reliability and innovation. "
Our global footprint is the foundation for our high-quality growth.
Against the backdrop of Japan's aging population and rising health consciousness, there is a significant increase in market demand for continuous health monitoring and management. The wearable health monitoring device market is booming, driven by integration with Internet of Things ( IoT ) technologies. ChoiceMMed's product lineup is highly aligned with this market trend. The company has obtained Japanese PMDA certification for several core products, laying a solid foundation for its market expansion.
Currently, ChoiceMMed has established subsidiaries in several key global markets, forming a strategic network covering Europe, North America, and Asia. The company will further advance the development of its localized operational system in Japan and strengthen its footprint in the Asia-Pacific market. By gaining deeper insights into regional market demands, ChoiceMMed aims to provide critical support for its global product and service strategy.
Under the global marketing strategy of its parent company, Tianjin Chasesun Pharmaceutical Co., Ltd., ChoiceMMed will continue to enhance its supply chain system, optimize resource allocation, and promote high-quality enterprise development. Through technological innovation, the company is committed to serving global health initiatives.